Akanda (AKAN) Competitors $1.18 -0.11 (-8.53%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.16 -0.01 (-1.27%) As of 08/8/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock AKAN vs. OBSV, NKGN, BCLI, MBIO, NLSP, PMCB, AEZS, CELZ, APLM, and CDIOShould you be buying Akanda stock or one of its competitors? The main competitors of Akanda include ObsEva (OBSV), NKGen Biotech (NKGN), Brainstorm Cell Therapeutics (BCLI), Mustang Bio (MBIO), NLS Pharmaceutics (NLSP), Nuvilex (PMCB), Aeterna Zentaris (AEZS), Creative Medical Technology (CELZ), Apollomics (APLM), and Cardio Diagnostics (CDIO). These companies are all part of the "pharmaceutical products" industry. Akanda vs. Its Competitors ObsEva NKGen Biotech Brainstorm Cell Therapeutics Mustang Bio NLS Pharmaceutics Nuvilex Aeterna Zentaris Creative Medical Technology Apollomics Cardio Diagnostics ObsEva (NASDAQ:OBSV) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Do institutionals & insiders have more ownership in OBSV or AKAN? 17.5% of ObsEva shares are owned by institutional investors. Comparatively, 1.0% of Akanda shares are owned by institutional investors. 14.4% of ObsEva shares are owned by insiders. Comparatively, 20.4% of Akanda shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, OBSV or AKAN? Akanda has higher revenue and earnings than ObsEva. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioObsEvaN/AN/A-$58.38M-$0.92N/AAkanda$840K2.01-$4.10MN/AN/A Does the media prefer OBSV or AKAN? In the previous week, ObsEva had 1 more articles in the media than Akanda. MarketBeat recorded 1 mentions for ObsEva and 0 mentions for Akanda. ObsEva's average media sentiment score of 0.00 equaled Akanda'saverage media sentiment score. Company Overall Sentiment ObsEva Neutral Akanda Neutral Is OBSV or AKAN more profitable? Akanda's return on equity of 0.00% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets ObsEvaN/A -416.36% -92.01% Akanda N/A N/A N/A Which has more volatility and risk, OBSV or AKAN? ObsEva has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. SummaryAkanda beats ObsEva on 6 of the 8 factors compared between the two stocks. Get Akanda News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AKAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKAN vs. The Competition Export to ExcelMetricAkandaMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.84M$10.57B$5.44B$9.61BDividend YieldN/A2.01%4.61%4.14%P/E RatioN/A19.8629.7624.84Price / Sales2.0121.90449.1298.65Price / CashN/A21.7436.4258.36Price / Book0.392.858.185.64Net Income-$4.10M$211.77M$3.26B$265.68M7 Day Performance7.27%3.02%6.79%4.90%1 Month Performance-12.59%2.11%0.93%0.78%1 Year Performance-54.96%-9.82%28.83%22.16% Akanda Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKANAkanda0.8594 of 5 stars$1.18-8.5%N/A-52.4%$1.84M$840K0.00110Gap DownOBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050NKGNNKGen Biotech0.4858 of 5 stars$0.17-10.5%N/A-86.3%$7.64MN/A-0.03N/AShort Interest ↑Gap UpBCLIBrainstorm Cell Therapeutics1.7143 of 5 stars$0.76+3.5%N/A-84.2%$7.50MN/A-0.2340News CoverageUpcoming EarningsGap DownMBIOMustang Bio0.1088 of 5 stars$1.65-13.4%N/A-89.7%$7.21MN/A-0.02100Positive NewsEarnings ReportUpcoming EarningsGap DownNLSPNLS PharmaceuticsN/A$1.98-2.2%N/A+1,007.7%$7.11MN/A0.006Positive NewsUpcoming EarningsAnalyst UpgradePMCBNuvilex1.4747 of 5 stars$1.04+1.5%N/A-55.4%$7.10MN/A1.404Positive NewsUpcoming EarningsAEZSAeterna ZentarisN/A$3.90-1.5%N/A-43.3%$6.99M$2.37M-0.2620Upcoming EarningsCELZCreative Medical Technology0.5113 of 5 stars$2.65-0.2%N/A+10.3%$6.85M$10K-0.695Positive NewsEarnings ReportAnalyst UpgradeAPLMApollomics0.0874 of 5 stars$6.20-2.7%N/A-64.3%$6.82M$1.49M0.0045Negative NewsCDIOCardio Diagnostics3.1325 of 5 stars$3.89-7.7%$60.00+1,444.4%-74.3%$6.76M$40K0.001Positive NewsUpcoming Earnings Related Companies and Tools Related Companies OBSV Competitors NKGN Competitors BCLI Competitors MBIO Competitors NLSP Competitors PMCB Competitors AEZS Competitors CELZ Competitors APLM Competitors CDIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AKAN) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akanda Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akanda With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
